<DOC>
	<DOC>NCT00199173</DOC>
	<brief_summary>This is a Phase III trial comparing hepatic intra-arterial injection of Yttrium-90 microspheres (selective internal radiation [SIR] spheres) versus infusional intravenous (IV) 5FU in colorectal cancer metastatic to the liver only and refractory to standard IV chemotherapy.</brief_summary>
	<brief_title>Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Histologically proven colorectal adenocarcinoma, metastatic to the liver only. Failure of prior chemotherapy for advanced colorectal cancer. Adequate laboratory values of hematologic, renal and liver function World Health Organization (WHO) performance status (PS) &lt;= 2 Written consent Pregnant or lactating patients Other tumor type than adenocarcinoma (leiomyosarcoma; lymphoma). Patients with cirrhosis or other chronic liver disease Thrombosis of the hepatic main artery of the portal vein Lung shunting &gt; 20% as determined by nuclear medicine breakthrough scan Patients with serum bilirubin &gt; 1.0 x upper limit of normal (ULN) or with AST and/or ALT and/or alkaline phosphatase &gt; 5 x ULN Patients with concurrent or within 4 week period administration of any other experimental drugs. Other serious illness or medical conditions.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>intraarterial hepatic injection</keyword>
	<keyword>yttrium loaded microspheres</keyword>
	<keyword>colorectal neoplasm metastatic to the liver</keyword>
</DOC>